Kaletra and Rash papular - a phase IV clinical study of FDA data

Summary:

Rash papular is reported as a side effect among people who take Kaletra (lopinavir; ritonavir), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Truvada, and have Dyslipidaemia.

The phase IV clinical study analyzes which people have Rash papular when taking Kaletra. It is created by eHealthMe based on reports of 22,879 people who have side effects when taking Kaletra from the FDA, and is updated regularly.

What is Kaletra?

Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. eHealthMe is studying from 23,070 Kaletra users. Check the latest studies of Kaletra.

What is Rash papular?

Rash papular (redness with papule) is found to be associated with 1,120 drugs and 1,330 conditions by eHealthMe. Check the latest studies of Rash papular.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

22,879 people reported to have side effects when taking Kaletra.
Among them, 21 people (0.09%) have Rash papular.

Among these 21 people:

How long have people been on Kaletra when they have Rash papular? *

What is the gender of people who have Rash papular when taking Kaletra? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Rash papular when taking Kaletra? *

What are other drugs people take besides Kaletra? *

Truvada: 7 people, 33.33%
Levothyroxine Sodium: 4 people, 19.05%
Lamictal: 4 people, 19.05%
Pravastatin Sodium: 4 people, 19.05%
Bactrim: 3 people, 14.29%
Combivir: 2 people, 9.52%
Pentamidine Isethionate: 2 people, 9.52%
Raltegravir: 2 people, 9.52%
Abacavir: 2 people, 9.52%
Clarithromycin: 2 people, 9.52%

What are other side effects people have besides Rash papular? *

Itching: 7 people, 33.33%
Fever: 6 people, 28.57%
Diarrhea: 5 people, 23.81%
Rash Pruritic (redness with itching): 5 people, 23.81%
Rashes (redness): 4 people, 19.05%
Chills (felling of cold): 4 people, 19.05%
Weight Decreased: 3 people, 14.29%
Blood Alkaline Phosphatase Increased: 3 people, 14.29%
Cytolytic Hepatitis (dissolution or destruction of a liver cell): 3 people, 14.29%
Drug Ineffective: 3 people, 14.29%

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 19.05%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 19.05%
Dyslipidaemia (abnormal amount of lipids): 4 people, 19.05%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 9.52%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 4.76%
Hypoaesthesia (reduced sense of touch or sensation): 1 person, 4.76%
Hiv Test Positive: 1 person, 4.76%
Depression: 1 person, 4.76%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Kaletra and have Rash papular?

- Check whether Rash papular is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kaletra:

Kaletra (23,070 reports)

Rash papular treatments and more:

Rash papular (25,753 reports)

Browse all side effects of Kaletra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash papular:

Rash papular (1,120 drugs)

Browse all the conditions that are associated with Rash papular:

Rash papular (1,330 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lopinavir; ritonavir (the active ingredients of Kaletra) and Kaletra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.